October 21, 2016
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: ‘Dropless’ formulation benefits practice, patients
CHICAGO — At the American Academy of Ophthalmology meeting here, Sydney L. Tyson, MD, discusses the advantages and remaining reimbursement challenges in his use of a “dropless” formulation (Imprimis Pharmaceuticals) in cataract surgery in his practice.